Skip to main content

Rubella

  • Chapter
  • First Online:
Neonatal Infections
  • 1327 Accesses

Abstract

Congenital rubella syndrome (CRS) results from fetal infection with rubella virus following primary maternal infection. CRS was initially described in 1941 by Gregg, an Australian ophthalmologist who noted cataracts and congenital heart defects among 71 infants born to mothers who had rubella infection during pregnancy. CRS did not gain widespread recognition until the worldwide rubella pandemic from 1962 to 1964. In the United States during that time, 20,000 infants developed CRS and an additional 10,000 stillbirths occurred. Live-attenuated rubella vaccine was developed in 1969, and routine immunization of young children and at-risk women of childbearing age has markedly reduced the incidence of CRS. Rubella and congenital rubella syndrome were declared eradicated in the United States in 2004 and in the Americas in 2015. However, rubella remains common in other parts of the world, and imported cases of CRS are still seen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lambert N, Strebel P, Orenstein W, Icenogle J, Poland GA. Rubella. Lancet. 2015;385:2297–307.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kanaan MN, Farrington CP. Matrix models for childhood infections: a Bayesian approach with applications to rubella and mumps. Epidemiol Infect. 2005;133:1009–21.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Lebo EJ, Kruszon-Moran DM, Marin M, et al. Seroprevalence of measles, mumps, rubella, and varicella antibodies in the United States population, 2009-2010. Open Forum Infect Dis. 2015;20:ofv006.

    Article  Google Scholar 

  4. Hyde TB, Kruszon-Moran D, McQuillan GM, et al. Rubella immunity levels in the United States population: has the threshold of viral elimination been reached? Clin Infect Dis. 2006;43(S3):S146–50.

    Article  PubMed  Google Scholar 

  5. Dykewicz CA, Kruszon-Moran D, McQuillan GM, et al. Rubella seropositivity in the United States, 1988-1994. Clin Infect Dis. 2001;33:1279–86.

    Article  PubMed  CAS  Google Scholar 

  6. Seither R, Calhoun K, Street EJ, et al. Vaccination coverage for selected vaccines, exemption rates, and provisional enrollment among children in kindergarten—United States, 2016-17 school year. MMWR. 2017;66:1073–80.

    PubMed  PubMed Central  Google Scholar 

  7. Walker TY, Elam-Evans LD, Singleton JA, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years—United States, 2016. MMWR. 2017;66:874–82.

    PubMed  PubMed Central  Google Scholar 

  8. Papania MJ, Wallace GS, Rota PA, et al. Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience. JAMA Pediatr. 2014;168:148–55.

    Article  PubMed  Google Scholar 

  9. Vynnycky E, Adams EJ, Cutts FT, et al. Using seroprevalence and immunization coverage data to estimate the global burden of congenital rubella syndrome, 1996-2010: a systematic review. PLoS One. 2016;11:e0149160.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Cradock-Watson JE, Miller E, Ridehalgh MK. Detection of rubella virus in fetal and placental tissues and in the throats of neonates after serologically confirmed rubella in pregnancy. Prenat Diagn. 1989;9:91–6.

    Article  PubMed  CAS  Google Scholar 

  11. Miller E, Cradock-Watson JE, Pollock TM. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet. 1982;2:781–4.

    Article  PubMed  CAS  Google Scholar 

  12. Collins IS. The incidence of congenital malformations following maternal rubella at various stages of pregnancy. Med J Aust. 1953;2:456–8.

    PubMed  CAS  Google Scholar 

  13. Gregg NM. Congenital cataract following German measles in the mother. Trans Ophthal Soc Austr. 1941;3:35–44.

    Google Scholar 

  14. Givens KT, Lee DA, Jones T, Ilstrup DM. Congenital rubella syndrome: ophthalmic manifestations and associated systemic disorders. Br J Opthalmol. 1993;77:358–63.

    Article  CAS  Google Scholar 

  15. Overall JC. Intrauterine virus infections and congenital heart disease. Am Heart J. 1972;84:823–33.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Wild NJ, Sheppard S, Smithells RW, Holzel H, Jones G. Onset and severity of hearing loss due to congenital rubella infection. Arch Dis Child. 1989;64:1280–3.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Munoz FM. Maternal immunization: an update for pediatricians. Pediatr Ann. 2013;42:153–8.

    Article  PubMed  Google Scholar 

  18. Bullens D, Smets K, Vanhaesebrouck P. Congenital rubella syndrome after maternal reinfection. Clin Pediatr. 2000;39:113–6.

    Article  CAS  Google Scholar 

  19. Centers for Disease Control and Prevention. Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. MMWR Recomm Rep. 2001;50(RR-12):1–23.

    Google Scholar 

  20. Grose C, Itani O, Weiner CP. Prenatal diagnosis of fetal infection: advances from amniocentesis to cordocentesis—congenital toxoplasmosis, rubella, cytomegalovirus, varicella virus, parvovirus, and human immunodeficiency virus. Pediatr Infect Dis J. 1989;8:459–68.

    Article  PubMed  CAS  Google Scholar 

  21. Jin L, Thomas B. Application of molecular and serological assays to case based investigations of rubella and congenital rubella syndrome. J Med Virol. 2007;79:1017–24.

    Article  PubMed  Google Scholar 

  22. Hubschen JM, Bork SM, Brown KE, et al. Challenges of measles and rubella laboratory diagnostics in the era of elimination. Clin Microbiol Infect. 2017;23:511–5.

    Article  PubMed  CAS  Google Scholar 

  23. Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2013;62(RR-4):13.

    Google Scholar 

  24. Centers for Disease Control and Prevention. Rubella vaccination during pregnancy—United States, 1971-1988. MMWR. 1989;38:289–93.

    Google Scholar 

  25. Yamada T, Mochizuki J, Hanaoka M, et al. Effects of campaign for postpartum vaccination on seronegative rate against rubella among Japanese women. BMC Infect Dis. 2014;14:152.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Vilajeliu A, Garcia-Basteiro AL, Valencia S, et al. Rubella susceptibility in pregnant women and results of a postpartum immunization strategy in Catalonia, Spain. Vaccine. 2015;33:1767–72.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joseph B. Cantey MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Cantey, J.B. (2018). Rubella. In: Cantey, J. (eds) Neonatal Infections. Springer, Cham. https://doi.org/10.1007/978-3-319-90038-4_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-90038-4_18

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-90037-7

  • Online ISBN: 978-3-319-90038-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics